Lactoferrin in relation to biological functions and applications: A review

International Journal of Dairy Science

Volumn 6, Issue 2, 2011, Pages 79-111

  El Loly, Mohamed Mansour ^a   Mahfouz, Mohamed Bahy ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Biological multi functions; Iron binding; Lactoferricin; Lactoferrin; Milk proteins

Indexed keywords

ANIMALIA; BOVINAE; MAMMALIA;

EID: 79958699963     PISSN: 18119743     EISSN: 18119751     Source Type: Journal    
DOI: 10.3923/ijds.2011.79.111     Document Type: Review

References (254)

1. Abdel-Salam, A.M., R. Jacob, A.I.A. El-Gawad, E.M. El-Sayed, M.B. Mahfouz and H.Y. Nairn, 2003. N-gbycosylation, intracellular transport and sorting of recombinant bovine lactoferrin in polar and non-polar epithelial cells. Milichwissenschaft, 58: 359-363.
2. Abdel-Salam, A.M, A.A. Khattab, M.M. Zahran and M.B. Mahfouz, 2006. Biosynthesis of bovine lactoferrin in Saccharomyces cervisiae and its anti-bacterial activity. Milchwissenschaft, 61: 14-18.
3. Abd El-Gawad, LA, E.M. El-Sayed, M.B. Mahfouz and A.M. Abd El-Salam, 1996. Changes of lactoferrin concentration in colostrum and milk from different species. Egypt. J. Dairy Sci, 24: 297-308.
4. Abd El-Gawad, LA, E.M. El-Sayed, A.M. Abd El-Salam, M.B. Mahfouz and H. Nairn, 2001a. Cloning and expression of cDNA encoding bovine lactoferrin in non-polar epithelial cells. Proceedings of the 8th Egyptian Conference of Dairy Science and Technology, Nov. 3-5, Cairo, Egypt, pp: 93-93.
5. Abd El-Gawad, LA, E.M. El-Sayed, A.M. El-Salam, M.B. Mahfouz and H. Nairn, 2001b. N-Glycosylation, intracellular transport and sorting of recombinant bovine lactoferrin in polar and non polar epithelial cells. Proceedings of the 8th Egyptian Conference of Dairy Science and Technology, Nov. 3-5, Cairo, Egypt, pp: 94-95.
6. Abd El-Gawad, LA, E.M. El-Sayed, A.M. Abdel-Salam, M.B. Mahfouz and H.Y. Nairn, 2003. Cloning and expression of cDNA encoding bovine lactoferrin in non-polar epithelial cells. Milichwissenschaft, 58: 470-473.
7. Abe, H, H. Saito, H. Miyakawa, Y. Tamura, S. Shimamura, E. Nagao and M. Tomita, 1991. Heat stability of bovine lactoferrin at acidic pH. J. Dairy Sci, 74: 65-71.
8. Adam, V, O. Zitka, P. Dolezal, L. Zeman and A. Horna et al., 2008. Lactoferrin isolation using monolithic column coupled with spectrometric or micro-amperometric detector. Sensors, 8: 464-487.
9. Adamik, B. and A. Walszczyk, 1996. Lactoferrin: Its role in defence against infection and immunotropic properties. Postepy Higieny Medycyny Doswiadczalnej, 50: 33-41.
10. Aisen, P. and A. Liebman, 1972. Lactoferrin and transferrin: A comparative study. Biochimica et Biophysica Acta, 257: 314-323.
11. Akin, D.T, M.Q. Lu, S.J. Lu, S. Kendall, J. Rundegren and R.R. Arnold, 1994. Bactericidal activity of different forms of lactoferrin. Adv. Exp. Med. Biol, 357: 61-70.
12. Al-Sheikh, H, 2009. Effect of lactoferrin and iron on the growth of human pathogenic Candida species. Pak. J. Biol. Sci, 12: 91-94.
13. Anderson, B.F, H.M. Baker, E.J. Dodson, GE. Norns, S.V. Rumball, J.M. Waters and E.N. Baker, 1987. Structure of human lactoferrin at 3.2-A resolution. Proc. Natl. Acad. Sci, 84: 1769-1773.
14. Appelmelk, B.J, Y.Q. An, M. Geerts, B.G. Thijs and H.A. De-Boer et al., 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun, 62: 2628-2632.
15. Arnold, R.R, M.F. Cole and J.R. Mcghee, 1977. A bactericidal effect for human lactoferrin. Science, 197: 263-265.
16. Arnold, R.R, M. Brewer and J.J. Gauthier, 1980. Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms. Infect. Immun, 28: 893-898.
17. Arnold, R.R, J.E. Russell, W.J. Champion and J.J. Gautheir, 1981. Bactericidal activity of human lactoferrin: Influence of physical conditions and metabolic state of the target microorganism. Infect. Immun, 32: 655-660.
18. Artym, J. and M. Zimecki, 2005. The role of lactoferrin in the proper development of newborns. Postepy Higienyi Medycyny Doswiadczalnej, 59: 421-432.
19. Atkinson, H.C. and E.J. Begg, 1988. The binding of drugs to major human milk whey proteins. Bn. J. Clin. Pharma, 26: 107-109.
20. Baer, A., M. Oroz and B. Blanc, 1979. Serological and fluorescene studies of the heat stability of bovine lactoferrine. J. Dairy Res., 46: 83-93.
21. Bagby, G.C. and R.M. Bennett, 1982. Feedback regulation of granulopoiesis: Polymerization of lactoferrin abrogates its ability to inhibit CSA production. Blood, 60: 108-112.
22. Baker, E.N., 1994. Structure and reactivity of transferrins. Adv. Inorganic Chem., 41: 389-463.
23. Baker, E.N. and H.M. Baker, 2005. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci, 62: 2531-2539.
24. Bannister, J.V., W.H. Bannister, H.A. Hill and P.J. Thornalley, 1982. Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin. Biochimica et Biophysica Acta, 715: 116-120.
25. Bar, E., I. Tiris, M. Miron, M. Bojita and G. Mihai, 2010. The relationship between the content of Immunoglobulin (IgG), lactoferrin and density in bovine colostrum-comp arative study. Bull. UASVM Amm. Sci. Biotechnol, 67: 70-74.
26. Baveye, S., E. Elass, J. Mazurier, G. Spik and D. Legrand, 1999. Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med., 37: 281-286.
27. Bellamy, W., M. Takase, H. Wakabayashi, K. Kawase and M. Tomita, 1992a. Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Applied Bacterid., 73: 472-479.
28. Bellamy, W., M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase and M. Tomita, 1992b. Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta, 1121: 130-136.
29. Bellamy, W.R., H. Wakabayashi, M. Takase, S. Shimamura and M. Tomita, 1993. Role of cell-binding in the antibacterial mechanism of lactoferricin B. J. Applied Microbiol., 75: 478-484.
30. Bellamy, W., K. Yamauchi, H. Wakabayashi, N. Takakura, S. Shimamura and M. Tomita, 1994. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of lactoferrin. Lett. Applied Microbiol., 18: 230-233.
31. Bevins, C.L., 1994. Antimicrobial peptides as agents of mucosal immunity. Ciba Foundation Symp., 186: 250-260.
32. Bezwoda, W.R. and N. Mansoor, 1986. Isolation and characterisation of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbent. Clin. Chem. Acta, 157: 89-93.
33. Bezwoda, W.R. and N. Mansoor, 1989. Lactoferrin from human breast milk and from neutrophil granulocytes. Comparative studies of isolation, quantitation, characterization and iron biding properties. Biomed. Chromatogr., 3: 121-126.
34. Blackberg, L. and O. Hernell, 1980. Isolation of lactoferrin from human whey by a single chromatographic step. Federation Eur. Biochem. Soc. Lett., 109: 180-183.
35. Boman, H.G., 1995. Peptide antibiotics and their role in innate immmunity. Annu. Rev. Immunol., 13: 61-92.
36. Bortner, C.A., R.D. Miller and R.R. Arnold, 1986. Bactericidal effect of lactofemn on Legionella pneumophilu. Infect. Immun., 51: 373-377.
37. Bortner, C.A, R.R. Arnold and R.D. Miller, 1989. Bactericidal effect of lactoferrin on Legionella pneumophilu: Effect of the physiological state of the organism. Can. J. Microbiol, 35: 1048-1051.
38. Brines, R.D. and J.H. Brock, 1983. The effect of trypsin and chymotrypsin on the in vitro antibacterial and iron-binding proprieties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apo-lactoferrin to proteolytic digestion. Biochimica et Biophysica Acta, 759: 229-235.
39. Brock, J.H, F. Arzabe, F. Lampreave and A. Pineiro, 1976. The effect of trypsin on bovine transferrin and lactoferrin. Biochimica et Biophysica Acta, 446: 214-225.
40. Brock, J, 1995. Lactoferrin: A multifunctional immunoregulatory protein. Immunol. Todays, 16: 417-419.
41. Brock, J.H, 1997. Lactoferrin structure-Function relationships: An overview. Exp. Biol. Med, 28: 3-23.
42. Brock, J.H, 2002. The physiology of lactoferrin. Biochem. Cell Biol, 80: 1-6.
43. Brodie, A.M., E.W. Ainscough, E.N. Baker, H.M. Baker, M.S. Shongwe and C.A. Smith, 1994. Synergism and substitution in the lactofenins. Adv. Exp. Med. Biol, 357: 33-44.
44. Broxmeyer, H.E, M. De-Sousa, A. Smithyman, P. Ralph, J. Hamilton, J.I. Kurland and J. Bognacki, 1980. Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood, 55: 324-333.
45. Buderus, S, J. Boone, D. Lyerly and M.J. Lentze, 2004. Fecal lactoferrin: A new parameter to monitor infliximab therapy. Digestive Dis. Sci, 49: 1036-1039.
46. Carlsson, A. and L. Bjorck, 1987. The effect of some indigenous antibacterial factors in milk on the growth of Bacillus stearothermophilus var. calidolactis. Milchwissenschaft, 42: 282-285.
47. Cheng, J.B, J.Q. Wang, D.P. Bu, G.L. Liu and C.G. Zhang et al, 2008. Factors affecting the lactoferrin concentration in bovine milk. J. Dairy Sci, 91: 970-976.
48. Chierici, R, G. Sawatzki, L. Tamisari, S. Volpato and V. Vigi, 1992. Supplementation of an adapted formula with bovine lactoferrin: 2. Effects on serum iron, ferritin and zinc levels. Acta Pediatrics, 81: 475-479.
49. Chierici, R, 2001. Antimicrobial actions of lactoferrin. Adv. Nutr. Res, 10: 247-269.
50. Cirioni, O, A. Giacometti, F. Barchiesi and G. Scalise, 2000. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J. Antimicro. Chemother, 46: 577-582.
51. Clamp, J.R. and J.M. Creeth, 1984. Some non-mucin components of mucus and their possible biological roles. Ciba Foundation Symp, 109: 121-136.
52. Coddeville, B, G. Strecker, J.M. Wieruszeski, J.F. Vliegenthart and H. Van-Halbeek et al., 1992. Heterogeneity of bovine lactotransferrin glycans. Characterization of α-D-Galp-(l->3)-β-D-Gal-and α-NeuAc-(2->6)-β-D-GalpNAc-(l->4)-β-D-GlcNAc-substituted N-lmked glycans. Carbohydrate Res, 236: 145-164.
53. Cornish, J, K.E. Callon, D. Naot, K.P. Palmano and T. Banovic et al., 2004. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology, 145: 4366-4374.
54. Cumberbatch, M, M. Bhushan, R.J. Dearman, I. Kimber and C.E. Griffiths, 2003. IL-lb-induced Langerhans' cell migration and TNF-α production in human skin: Regulation by lactoferrin. Clin. Exp. Immunol, 132: 352-359.
55. Devi, A.S, M.R. Das and M.W. Pandit, 1994. Lactoferrin contains structural motifs of ribonuclease. Biochimica et Biophysica Acta, 1205: 275-281.
56. Dial, E.J., A.J. Dohrman, J.J. Romero and L.M. Lichtenberger, 2005. Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J. Pharmacy Pharm., 57: 93-99.
57. Dionysius, D.A. and J.M. Milne, 1997. Antibacterial peptides of bovine lactoferrin: Purification and characterization. J. Dairy Sci., 80: 667-674.
58. Dziadek, B., J. Dziadek and H. Dlugonska, 2007. Identification of Toxoplasma gondii proteins binding human lactoferrin: A new aspect of rhoptry proteins function. Exp. Parasitol., 115: 277-282.
59. Egashira, M., T. Takayanagi, M. Moriuchi and H. Moriuchi, 2007. Does daily intake of bovine lactoferrin containing products ameliorate rotaviral gastroenteritis?. Acta Paediatrics, 96: 1238-1244.
60. El-Sayed, E.M., MB. Mahfouz, A.M. Abdel-Salam, LA. Abd El-Gawad and H.Y. Nairn, 2003. Antimicrobial activity of recombinant bovine lactoferrin and lactoferricin B and glycosylation human lysozyme. Milichwissenschaft, 58: 266-270.
61. Elagamy, E.I., R. Ruppanner, A. Ismail, CP. Champagne and R. Assaf, 1996. Purification and characterization of lactoferrin, lactoperoxidase, lysozyme and immunoglobulins from camel's milk. Int. Dairy J, 6: 129-145.
62. Elass-Rochard, E., A. Roseanu, D. Legrand, M. Trif and V. Salmon et al., 1995. Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lip op oly saccharide. Biochem. J, 312: 839-845.
63. Ellison, R.T. 3rd, F.M. LaForce, T.J. Giehl, D.S. Boose and BE. Dunn, 1990. Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+. J. Genet. Microbiol, 136: 1437-1446.
64. Ellison, R.T. 3rd and T.J. Giehl, 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest, 88: 1080-1091.
65. Ellison, R.T. III, 1994. The effects of lactoferrin on gram-negative bacteria. Adv. Exp. Med. Biol, 357: 71-90.
66. Ena, J.M, H. Castillo, L. Sanchez and M. Calvo, 1990. Isolation of human lactoferrin by affinity chromatography using insolubilized bovine B-lactoglobulin. J. Chromatogr. Biomed. Sci. Appl, 525: 442-446.
67. Ensminger, A.H. and M.K.J. Esminger, 1986. Food for Health: A Nutrition Encyclopedia. Pegus Press, California.
68. Erdei, J, A. Forsgren and A.S. Naidu, 1994. Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect. Immunity 62: 1236-1240.
69. Facon, M.J, 1996. Antibacterial factors of cow's milk and colostrom: Immunoglobulin and lactoferrin. Dissert Abs. B, 56: 4077-4077.
70. Facon, M.J. and B.J. Skura, 1996. Antibacterial activity of lactoferricin, lysozyme and EDTA against Salmonella enteritidis. Int. Dairy J, 6: 303-313.
71. Farnaud, S. and R.W. Evans, 2003. Lactoferrin-A multifunctional protein with antimicrobial properties. Mol. Immunol, 40: 395-405.
72. Furmanski, P, Z.P. Li, MB. Fortuna, C.V.B. Swamy and M.R. Das, 1989. Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity. J. Exp. Med, 170: 415-429.
73. Gifford, J.L, H.N. Hunter and H.J. Vogel, 2005. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci, 62: 2588-2598.
74. Goldman, A.S, C. Garza, R.J. Schanler and R.M. Goldblum, 1990. Molecular forms of lactoferrin in stool and urine from infants fed human milk. Pediatrics Res, 27: 252-255.
75. Greenberg, D.E, Z.D. Jiang, R. Steffen, M.P. Verenker and H.L. DuPont, 2002. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J. Infect. Dis, 185: 944-949.
76. Groves, M.L, 1960. The isolation of a red protein from milk. J. Am. Chem. Soc, 82: 3345-3350.
77. Guerrant, R.L, V. Araujo, E. Soares, K. Kotloff, A.A. Lima, W.H. Cooper and A.G. Lee, 1992. Measurement of fecal lactoferrin as a marker of fecal leucocytes. J. Clin. Microbiol, 30: 1238-1242.
78. Guillen, C, LB. Mclnnes, D. Vaughan, A.B. Speekenbrink and J.H. Brock, 2000. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheumatism, 43: 2073-2080.
79. Hagiwara, S, K. Kawai, A. Anri and H. Nagahata, 2003. Lactoferrin concentrations in milk from normal and subclinical mastitic cows. J. Vet. Med. Sci, 65: 319-323.
80. Hammer, J, H. Haaheim and T.J. Gutteberg, 2000. Bovine lactoferrin is more efficient than bovine lactoferricin in inhibiting HSV-I/-II replication in vitro. Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications, May 18-22, Sapporo, Japan, pp: 239-243.
81. Hancock, R.E.W, 1997. Peptide antibiotics. Lancet, 349: 418-422.
82. Hancock, R.E.W. and R. Lehrer, 1998. Cationic peptides: A new source of antibiotics. Trends Biotechnol, 16: 82-88.
83. Hancock, R.E.W. and D.S. Chappie, 1999. Antibiotic peptides. Antimicrobial Agents Chemother, 43: 1317-1323.
84. Hancock, R.E.W. and G. Diamond, 2000. Cationic antimicrobial peptides: A major element in mammalian innate immune defences against infection. Trends Microbol, 8: 402-410.
85. Harmon, R.J, F.L. Schanbacher, L.C. Ferguson and K.L. Smith, 1975. Concentration of lactoferrin in milk of normal lactating cows and changes occurring during mastitis. Am. J. Vet. Res, 36: 1001-1007.
86. Harmsen, M.C, P.J. Swart, M.P. De-Bethune, R. Pauwels, E. De-Clercq, T.H. The and D.K. Meijer, 1995. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis, 172: 380-388.
87. Hashizume, S, K. Kuroda and H. Murakami, 1983. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium. Biochim. Biophys. Acta, 763: 377-382.
88. Haversen, L, B.G. Ohlsson, M. Hahn-Zoric, LA. Hanson and I. Mattsby-Baltzer, 2002. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immun, 220: 83-95.
89. Hoek, K.S, J.M. Milne, P.A. Grieve, D.A. Dionysius and R. Smith, 1997. Antibacterial activity in bovine lactoferrin-derived peptides. Antimicrob. Agents Chemother, 41: 54-59.
90. Hurley, W.L, R.C.J. Grieve, C.E. Magura, H.M. Hegarty and S. Zou, 1993. Electrophoretic comparisons of lactoferrin from bovine mammary secretions, milk neutrophils and human milk. J. Dairy Sci, 76: 377-387.
91. Hutchens, T.W, J.F. Henry and T.T. Yip, 1989a. Purification and characterization of intact lactoferrin found in the urine of human milk-fed preterm infants. Clin. Chem, 35: 1928-1933.
92. Hutchens, T.W, J.S. Magnuson and T.T. Yip, 1989b. Rapid purification of porcine colostral whey lactoferrin by affinity chromatography on single-stranded DNA-agarose, characterization, amino acid composition and N-terminal amino acid sequence. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol, 999: 323-329.
93. Hutchens, T.W, J.F. Henry, T.T. Yip, D.L. Hachey, R.J. Schanler, K.J. Motil and C. Garza, 1991. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment. Pediatrics Res, 29: 243-250.
94. Hwang, P.M., N. Zhou, X. Shan, C.H. Arrowsmith and H.J. Vogel, 1998. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferricin. Biochemistry, 37: 4288-4298.
95. Hyvnen, P, 2010. Lactoferrin in bovine intramammary infection Ph.D. Thesis, Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland.
96. IDF (International Dairy Federation), 1988. Code of practice for preservation of raw milk by use of the lactoproxidase system. Document, pp: 234.
97. Indyk, H.E. and E.L. Filonzi, 2005. Determination of lactoferrin in bovine milk, colostrum and infant formulas by optical biosensor analysis. Int. Dairy J, 15: 429-438.
98. Ishii, K, N. Takamura, M. Shinohara, N. Wakui and H. Shin et al., 2003. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hep at ology Res, 25: 226-233.
99. Itagaki, T, M. Yoshida, S. Abe, H. Omichi and Y. Nishihira, 1993. Separation of human tear proteins with ceramic hydroxy apatite high-performance liquid chromatography. J. Chromatog, Biomed. Appl, 320: 149-152.
100. Jameson, G.B, B.F. Anderson, GE. Norris, D.H. Thomas and E.N. Baker, 1998. Structure of human apolactoferrin at 2.0 a resolution, refinement and analysis of ligand-induced conformational change. Acta Crystallogr, Sect. D: Biol. Crystallogr. 55: 1108-1108.
101. Jenssen, H. and R.E.W. Hancock, 2009. Antimicrobial properties of lactoferrin. Biochimie, 91: 19-29.
102. Johansson, B.G. and S. Hjerten, 1960a. Electrophoresis, crossed immunoelectrophoresis and isoelectric focusing in agarose gels with reduced electroendosmotic flow. Anal. Biochem, 59: 200-213.
103. Johansson, B.G. and S. Hjerten, 1960b. Isolation of an iron containing red protein from human milk. Acta Chem. Scand, 14: 510-512.
104. Jones, E.M, A. Smart, G. Bloomberg, L. Burgess and M.R. Millar, 1994. Lactoferricin, a new antimicrobial peptide. J. Applied Microbiol, 77: 208-214.
105. Joslm, R.S, P.S. Erickson, H.M. Santoro, N.L. Whitehouse, C.G. Schwab and J.J. Rejman, 2002. Lactoferrin supplementation to dairy calves. J. Dairy Sci, 85: 1237-1242.
106. Kalmar, I.R. and R.R. Arnold, 1988. Killing of actinobacillus actinomycetemcomitans by human lactoferrin. Infec. Immun, 56: 2552-2557.
107. Kane, S.V, W.J. Sandborn, P.A. Rufo, A. Zholudev and J. Boone et al., 2003. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenter, 98: 1309-1314.
108. Kanyshkova, T.G, SE. Babina, D.V. Semenov, N. Isaeva and A.V. Valssov et al., 2003. Multiple enzymic activities of human milk lactoferrin. Eur. J. Biochem, 270: 3353-3361.
109. Kawaguchi, S, T. Hayashi, J. Masano, K. Okuyama, T. Suzuki and K. Kawase, 1989. A study concerning the effect of lactoferrin-enriched infant formula on low birth weight infants. J. Perinatal Med, 19: 557-562.
110. Kawakami, H, H. Shinmoto, S. Dosako and Y. Sago, 1987. One-step isolation of lactoferrin using immobilized monoclonal antibodies. J. Dairy Sci, 70: 752-759.
111. Kawakami, H, S. Dosako and B. Lonnerdal, 1990. Iron up-take from transferrin and lactoferrin by rat intestinal brush-border membrane vesicles. Am. J. Physiol, 258: 535-541.
112. Kijlstra, A, S.H. Jeurissen and K.M. Koning, 1983. Lactoferrin levels in normal human tears. Br. J. Ophthalmology, 67: 199-202.
113. King, Jr. J.C, G.E. Cummings, N. Guo, L. Trivedi and B.X. Readmond et al., 2007. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J. Pediatric Gastroenterology Nutr, 44: 245-251.
114. Kirkpatrick, C.H, I. Green, R.R. Rich and A.L. Schade, 1971. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis, 124: 539-544.
115. Konuspayeva, G, B. Faye, G. Loiseau and D. Levieux, 2007. Lactoferrin and immunoglobulin contents in camel's milk (Camelus bactrianus, Camelus dromedarius and hybrids) from Kazakhstan. J. Dairy Sci, 90: 38-46.
116. Korhonen, H. and A. Pihlanto, 2006. Bioactive peptides: Production and functionality. Int. Dairy J, 16: 945-960.
117. Kmpers, M.E, H.G. de Vries, M.C. Eikelboom, D.K.F. Meijer and P.J. Swart, 1999. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother, 43: 2635-2641.
118. Kussendrager, K, 1993. Lactoferrin and lactoperoxydase. Int. Food Ingredients, 6: 17-21.
119. Kussendrager, K, 1994. Effects of Heat Treatment on Structure and Iron-Binding Capacity of Bovine Lactoferrin. IDF Bulletin: Indigenous Antimicrobial Agents of Milk: Recent Developments. Uppsala, Sweden, pp: 133-146.
120. Lassiter, M.O, A.L. Newsome, L.D. Sams and R.R. Arnold, 1987. Characterization of lactoferrin interaction with Streptococcus mutans. J. Deizt Res, 66: 480-485.
121. Law, B.A. and B. Reiter, 1977. The isolation and bacteriostatic properties of lactoferrin from bovine milk whey. J. Dairy Res, 44: 595-599.
122. Legrand, D, J. Mazurier, M.H. Metz-Boutigue, J. Jolles, P. Jolles, J. Montreuil and G. Spik, 1984. Characterization and localization of an iron-binding 18-kDa glycopeptide isolated from the N-terminal half of human lactotransferrin. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol, 787: 90-96.
123. Legrand, D, J. Mazurier, J. Montreuil and G. Spik, 1988. Structure and spatial conformation of the iron-binding sites of transferring. Biochimie, 70: 1185-1195.
124. Legrand, D, J. Mazurier, A. Elass, E. Rochard and G. Vergoten et al., 1992. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemisrty, 31: 9243-9251.
125. Legrand, D, E. Elass, M. Carpentier and J. Mazurier, 2005. Lactoferrin: A modulator of immune and inflammatory responses. Cell Mol. Life Sci, 62: 2549-2559.
126. Legrand, D, A. Pierce, E. Elass, M. Carpentier, C. Mariller and J. Mazurier, 2008. Lactoferrin Structure and Functions. In: Bioactive Components of Milk, Bosze, Z. (Ed.). Springer, Hungary, ISBN-13: 9780387740867, pp: 163-194.
127. Levay, P.F. and M. Viljoen, 1995. Lactoferrin: A general review. Haematologica, 80: 252-267.
128. Levieux, D, F. Morgan, N. Geneix, I. Masle and F. Bouvier, 2002. Caprine immunoglobulin G, P-lactoglobulin, a-lactoalbumin and serum albumin in colostrum and milk during the early post partum period. J. Dairy Res, 69: 391-399.
129. Lima, M.F, L.A. Beltz and F. Kierszenbaum, 1988. Trypanosoma cruzi: A specific surface marker for the amastigote form. J. Eukaryotic Microbiol, 35: 108-110.
130. Ling, J.M. and AB. Schryvers, 2006. Perspectives on interactions between lactoferrin and bacteria. Biochem. Cell Biol, 84: 275-281.
131. Lonnerdal, B. and S. Iyer, 1995. Lactoferrin: Molecular structure and biological function. Annu. Rev. Nutr, 75: 93-110.
132. Lonnerdal, B, 2009. Nutritional roles of lactoferrin. Curr. Opin. Clin. Nutr. Metab. Care, 12: 293-297.
133. Lorget, F, J. Clough, M. Ohveira, M.C. Daury, A. Sabokbar and E. Offord, 2002. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem. Biophys. Res. Commun, 296: 261-266.
134. Lyer, S. and B. Lonnerdal, 1993. Lactoferrin, lactoferrin receptors and iron metabolism. Eur. J. Clin. Nutr, 47: 232-241.
135. Machnicki, M, M. Zimecki and T. Zagulski, 1993. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Patho, 74: 433-439.
136. Mahfouz, MB, E.M. El-Sayed, I.A.A. El-Gawad, H. El-Etnby and A.M.A. El-Salam, 1997. Structural studies on colostrum and milk lactoferrins from different species. Egyptian J. Dairy Sci, 25: 41-53.
137. Malmquist, J. and B.G. Johansson, 1971. Interaction of lactoferrin with agar gels and with trypan blue. Biochim. Biophys. Acta, Protein Struct, 236: 38-46.
138. Malmquist, J, NE. Hansen and H. Karle, 1978. Lactoferrin in haematology. Scand. J. Haemato, 21: 5-8.
139. Mann, D.M, E. Romm and M. Migliorini, 1994. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biology Chem, 269: 23661-23667.
140. Marchetti, M, C. Longhi, M.P. Conte, S. Pisani, P. Valenti and L. Seganti, 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiv. Res, 29: 221-231.
141. Marnila, P. and H. Korhonen, 2009. Lactoferrin for Human Health. In: Dairy-Derived Ingredients: Food and Nutraceutical Uses. Corredig, M, (Ed.). Taylor and Francis, Cambridge, UK, ISBN-13: 9781439820704, pp: 290-307.
142. Martin, E, T. Gantz and R. Lehrer, 1995. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukocytes Biol, 58: 128-136.
143. Martins, C.A, M.G. Fonteles, L.J. Barrett and R.L. Guerrant, 1995. Correlation of lactoferrin with neutrophilic inflammation in body fluids. Clin. Diagn. Lab. Immuno, 2: 763-765.
144. Masada, S, Y. Yamane, K. Shimoda, T. Shimoda and S. Nakaniwa et al., 1995. Clinical use of SK-1 for dermatotherapy in dogsandcats. J. Anim. Clin. Res. Found, 3: 37-43.
145. Masson, P.L. and J.F. Heremans, 1966. Studies on lactoferrin, their on biding protein of secretions. Protides Biol. Fluid, 14: 115-124.
146. Masson, P.L, J.F. Heremans and C.H. Dive, 1966. An iron-binding protein common to many external secretions. Clin. Chemis. Acta, 14: 735-739.
147. Masson, P.L. and J.F. Heremans, 1971. Lactoferrin in milk from different species Comp. Biochem. Physiol. B: Comp. Biochem, 39: 119-129.
148. Mazurier, J. and G. Spik, 1980. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lacto-transferrin. Biochim. Biophys. Acta, Gen. Subj, 629: 399-408.
149. Mazurier, J, J. Montreuil and G. Spik, 1985. Visualization of lactotransferrin brush-border receptors by ligand-blotting. Biochim. Biophys. Acta, Biomembr, 821: 453-460.
150. Medina, I, I. Tombo, M.T. Satue-Gracia, J.B. German and E.N. Frankel, 2002. Effects of natural phenolic compounds on the antioxidant activity of lactoferrin in liposomes and oil-in-water emulsions. J. Agric. Food Chem, 50: 2392-2399.
151. Metz-Boutigue, M.H, J. Jolles, J. Mazurier, F. Schoentgen, D. Legrand et al., 1984. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem, 145: 659-676.
152. Meulenbroek, A.J. and W.P. Zeijlemaker, 1996. Human IgG Subclasses: Useful Diagnostic Markers for Immunocompetence: Useful Diagnostic Markers for Immunocompetence. 2nd Edn, CLB, Plesmanlaan, Amsterdam, Holland, ISBN-13: 9789052670119, pp: 52.
153. Miyauchi, H, A. Kaino, I. Shinoda, Y. Fukuwatari and H. Hayasawa, 1997. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer's Patch cells. J. Dairy Sci, 80: 2330-2339.
154. Moguilevsky, N, L.A. Retegui and P.L. Masson, 1985. Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem. J, 229: 353-359.
155. Moguilevsky, N, P.L. Masson and P.J. Courtory, 1987. Lactoferrin uptake and iron processing into macrophages: A study in familial haemochromatosis. Br. J. Haemat, 66: 129-136.
156. Mohan, C.K.V, R. Kumaraguruparan, D. Prathiba and S. Nagini, 2006. Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin. Nutrition, 22: 940-946.
157. Montreuil, J, J. Tonnelat and S. Mullet, 1960. Preparation and properties of lactosiderophilin (lactotransferrin) of human milk. Biochim. Biophys. Acta, 45: 413-421.
158. Moore, S.A, B.F. Anderson, C.R. Groom, M. Haridas and E.N. Baker, 1997. Three-dimensional structure of diferric bovine lactoferrin at 208A resolution. J. Mol. Biol, 274: 222-236.
159. Moshynskyy, I, M. Jiang, M.C. Fontaine, J. Perez-Casal, L.A. Babiuk and A.A. Potter, 2003. Characterization of a bovine lactoferrin binding protein of Streptococcus uberis. Microb. Pathogenesis, 35: 203-215.
160. Nagasawa, T, I. Kiyosawa and K. Kuwahara, 1972. Amounts of lactoferrin in human colostrum and milk. J. Dairy Sci, 55: 1651-1659.
161. Naidu, A.S, M. Andersson and A. Forsgren, 1992. Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J. Med. Microbio, 36: 177-183.
162. Naidu, S.S. and R.R. Arnold, 1994. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. Diagn. Microbiol. Infectious Dis, 20: 69-75.
163. Naidu, S.A, 2002. Activated lactoferrin-A new approach to meat safety. Food Tech, 56: 40-45.
164. Naidu, A.S, J. Chen, C. Martinez, J. Tulpmski, B.K. Pal and R.S. Fowler, 2004. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer. J. Reprod. Med, 49: 859-866.
165. Nikaido, H. and M. Vaara, 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev, 49: 1-32.
166. Oddy, W.H, 2002. Why breast milk has health benefits for infants and children: A review. Pak. J. Nutr, 1: 106-118.
167. 53 gene through induction of NF-kappaB activation cascade. Oncogene, 23: 8282-8291.
168. Okuda, M, T. Nakazawa, K. Yamauchi, E. Miyashiro and R. Koizumi et al., 2005. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: A randomized, double-blind, placebo-controlled study. J. Infec. Chemother, 11: 265-269.
169. Omata, Y, M. Satake, R. Maeda, A. Saito and K. Shimazaki et al., 2001. Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J. Vet. Med. Sci, 63: 187-190.
170. Orsi, N, 2004. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals, 17: 189-196.
171. Otsuki, K, A. Yoda, Y. Mitsuhasuhashik, Y. Shimizue, H. Saito, T. Yanaihara and Y. Makino, 2000. Isolation and detection of human lactoferrin binding protein in human aminotic membrane. Excerpta Med. Int. Congr. Ser, 1195: 343-346.
172. Pahud, J.J. and H. Hilpert, 1976. Affinity chromatography of lactoferrin on immobilized ferritin. Protides Biol. Fluids Proc. Colloquium, 23: 571-574.
173. Parsi, M.A, S.N. Saadeh, N.N. Zein, G.L. Davis and R. Lopez et al., 2008. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology, 135: 803-807.
174. Pierce, A, D. Colavizza, M. Bennaissa, P. Maes, A. Tartar, J. Montreuil and G. Spik, 1991. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem, 196: 177-184.
175. Pietrantoni, A, A.M. Di Biase, A. Tmari, M. Marchetti, P. Valenti, L. Seganti and F. Superti, 2003. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicro. Agents Chemother, 47: 2688-2691.
176. Powell, M.J. and JE. Ogden, 1990. Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res, 18: 4013-4013.
177. Prieels, J.P, S.V. Pizzo, L.R. Glasgow, J.C. Paulson and R.L. Hill, 1978. Hepatic receptor that specifically binds oligosaccharides containing fucosyl al leads to 3 N-acetylglucosamine linkages. Proc. Natl. Acad. Sci. USA, 75: 2215-2219.
178. Prinz, T, M. Meyer, A. Pettersson and J. Tommassen, 1999. Structural characterization of the lactoferrin receptor from Neisseria meningitidis. J. Bacterio, 181: 4417-4419.
179. Rado, T.A, J.S. Bollekens, G. Laurent, L. Parker and E.J. Benz, Jr., 1984. Lactoferrin biosynthesis during granulocytopoiesis. Blood, 64: 1103-1109.
180. Reghunathan, R, M. Jayapal, H. Li-Yang, C. Hiok-Hee, D. Tai, B.P. Leung and A.J. Melendez, 2005. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol, 6: 1-11.
181. Reiter, B, 1985. The biological significance of the non-immunological protective proteins in milk: Lysozyme, lactoferrin, lactoperoxidase. Develop. Dairy Chem, 3: 281-336.
182. Rey, M.W, S.L. Woloshuk, H.A. deBoer and F.R. Pieper, 1990. Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res, 18: 5288-5288.
183. Robblee, E.D, P.S. Erickson, N.L. Whitehouse, A.M. McLaughlin, C.G. Schwab, J.J. Rejman and RE. Rompala, 2003. Supplemental lactoferrin improves health and growth of holstein calves during the preweaning phase. J. Dairy Sci, 86: 1458-1464.
184. Roberts, A.K, R. Chierici, G. Sawatzki, M.J. Hill, S. Volpato and V. Vigi, 1992. Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatrics, 81: 119-124.
185. Rodrigues, L, J. Teixeira, F. Schmitt, M. Paulsson and H.L. Mansson, 2009. Lactoferrin and cancer disease prevention. Crit. Rev. Food Sci. Nutr, 49: 203-217.
186. Ruegg, M, U. Moor and B. Blanc, 1977. A calorimetric study of the thermal denaturation of whey proteins in simulated milk ultrafiltrate. J. Dairy Res, 44: 509-520.
187. Saito, H, H. Miyakawa, Y. Tamura, S. Shimamura and M. Tomita, 1991. Potent bactericidal activity of bovine lactoferrin hydrolysate produced by heat treatment at acidic pH. J. Dairy Sci, 74: 3724-3730.
188. Sallmann, F.R, S. Baveye-Descamps, F. Pattus, V. Salmon, N. Branza, G. Spik and D. Legrand, 1999. Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects. J. Biol. Chem, 274: 16107-16114.
189. Sato, R, O. Inanami, Y. Tanaka, M. Takase and Y. Naito, 1996. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in Feline Immunodeficiency Virus (FIV)-positive and FIV-negative cats. Am. J. Vet. Res, 57: 1443-1446.
190. Satue-Gracia, M.T, E.N. Frankel, H. Rangavajhyala and J.B. German, 2000. Lactoferrin in infant formulas: Effect on oxidation. J. Agric. Food Chem, 48: 4984-4990.
191. Schafer, K.H, 1951. Electrophoretic studies on milk protein problem. Mon. Kindrlzeilkunde, 99: 69-71.
192. Schibli, D.J, P.M. Hwang and H.J. Vogel, 1999. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. Fed. Eur. Biochem. Soc. Lett, 446: 213-217.
193. Schryvers, A.B, R. Bonnah, R.H. Yu, H. Wong and M. Retzer, 1998. Bacterial lactoferrin receptors. Excerpta Med. Int. Congr. Ser, 1195: 55-65.
194. Sekine, K, Y. Ushida, T. Kuhara, M. Iigo and H. Baba-Toriyama et al., 1997. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett, 121: 211-216.
195. Sharma, A.K, S. Karthikeyan, S. Sharma, S. Yadav, A. Srinivasan and T.P. Singh, 1998. Structures of buffalo and mare lactoferrins. Similarities, differences and flexibility. Adv. Exp. Med. Biol, 443: 15-21.
196. Shimakaki, K.I, N. Kawano and Y.C. Yoo, 1991. Comparison of bovine, sheep and goat milk lactoferrins in their electrophoretic behaviour, conformation, immunochemical properties and lectin reactivity. Comp. Biochem. Phys. B: Comp. Biochem, 98: 417-422.
197. Shimazaki, K.I, A. Kawaguchi, T. Sato, Y. Ueda, T. Tommimura and S. Shimanlura, 1993. Analysis of human and bovine milk lactoferrins by Rotofor and chromatofocusing. Int. J. Chem, 25: 1653-1658.
198. Shimazaki, K.I, 2000a. Lactoferrin. A marvelous protein in milk. Anim. Sci. J, 71: 329-347.
199. Shimazaki, K.I, 2000b. Lactoferrin: Structure, Function and Applications. Elsevier Science B.V, New York, ISBN-13: 9780444503176.
200. Shimizu, K.I, H. Matsuzawa, K. Okada, S. Tazume and S. Dosako et al., 1996. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol, 141: 1875-1889.
201. Shinmoto, H, S. Dosako and I. Nakajima, 1992. Antioxidant activity of bovine lactoferrinon iron/ascorbate induced lipid peroxidation. Biosci. Biotech. Biochem, 12: 2079-2080.
202. Shinoda, I, Y. Fukuwatari, S. Shimamura and M. Tomita, 1993. Stimulation by bovine lactoferrin of nerve growth factor synthesis/secretion in mouse L-M cells. Biosci. Biotech. Biochem,57: 890-893.
203. Shinoda, I, M. Takase, Y. Fukuwateri, S. Shimamura, M. Roller and W. Konig, 1996. Effect of lactoferrin and lactoferricin on the release of interleukcin 8 from human polymorphonuclear leukocytes. Biotech. Biochem, 60: 521-523.
204. Sorensen, M. and S.P.L. Sorensen, 1940. The proteins in whey. Rep. Lab. Work, 23: 55-99.
205. Spik, G, B. Coddeville and J. Montreuil, 1988. Comparative study of the primary structures of sero-, lacto- and ovotransferrin glycans from different species. Biochimie, 70: 1459-1469.
206. Spik, G, B. Coddeville, J. Mazurier, Y. Boune, C. Cambillaut and J. Montreuil, 1994. Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans. Adv. Exp. Med. Biol, 357: 21-32.
207. Spik, G, D. Legrand, J. Mazurier, A. Pierce and J.P. Perraudin, 1998. Advances in Lactoferrin Research. 1st Edn, Plenum Press, New York, USA, ISBN-13: 978-0306459269, pp: 368.
208. Steijns, J.M. and A.C. van Hooijdonk, 2000. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br. J. Nutr, 84: S11-S17.
209. Steijns, J.M, 2001. Milk ingredients as nutraceuticals. Int. J. Dairy Technol, 54: 81-88.
210. Suzuki, T, M. Nonaka, I. Kiosawa and K. Ogasa, 1977. Lactoferrin contents in bovine colostrums and milk. Eiyou Shokuryou, 30: 317-322.
211. Suzuki, Y.A, V. Lopez and B. Lonnerdal, 2005. Mammalian lactoferrin receptors: Structure and function. Cell. Mol. Life Sci, 62: 2560-2575.
212. Swart, P.J, ME. Kuipers, C. Smit, R. Pauwels and M.P. deBethune et al., 1996. Antiviral effects of milk proteins: Acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. Aids Res. Hum. Retroviruses, 12: 769-775.
213. Swart, P.J, ME. Kuipers, C. Smit, B.W. Van der Strate, M.C. Harmsen and D.K. Meijer, 1998. Lactoferrin. Antiviral activity of lactoferrin. Adv. Exp. Med. Biol, 443: 205-213.
214. Tachezy, J, J. Kulda, I. Bahnikova, P. Suchan, J. Razga and J. Schrevel, 1996. Tritrichomonas foetus: Iron acquisition from lactoferrin and transferrin. Exp. Parasit, 83: 216-228.
215. Takayanagi, N, Y. Niida and C. Chiba, 1986. As chemical mediator on inflammation and immunity. Shounika-Rinshou, 39: 1287-1293.
216. Tanaka, K, M. Ikeda and N. Kato, 2000a. Property of lactoferrin and its application in patients with chronic hepatitis C. Bio Ind, 17: 45-51.
217. th International Conference on Lactoferrin: Structure, Function and Applications, May 18-22, Sapporo, Japan, pp: 361-367.
218. Tanaka, T, K. Kawabata, H. Khno, S. Honjo and M. Murakami et al., 2000c. Bovine lactoferrin inhibits rat tongue carcinogenesis. Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications, May 18-22, Sapporo, Japan, pp: 401-411.
219. Taylor, S, J. Brock, C. Kruger, T. Berner and M. Murphy, 2004. Safety determination for the use of bovine milk-derived lactoferrin as a component of an antimicrobial beef carcass spray. Regul. Toxicol. Pharm, 39: 12-24.
220. Teng, C.T, C. Beard and W. Gladwell, 2002. Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat and hamster. Biol. Reprod, 67: 1439-1449.
221. Teraguchi, S, K. Shin, T. Ogata, M. Kingaku and A. Kaino et al., 1995. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk. Applied Envirn. Microbiol, 61: 4131-4134.
222. Teraguchi, S, H. Wakabayashi, H. Kuwata, K. Yamauchi and Y. Tamura, 2004. Protection against infections by oral lactoferrin: Evaluation in animal models. Biometals, 17: 231-234.
223. Tomita, M, W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi and K. Kawase, 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci, 74: 4137-4142.
224. Tomita, S, N. Shirasaki, H. Hayashizaki, J. Matsuyama, Y. Benno and I. Kiyosawa, 1998. Binding characteristics of bovine lactoferrin to the cell surface of Clostridium species and identification of the lactoferrin-binding protein. Biosci, Biotech. Biochem, 62: 1476-1482.
225. Tomita, M, H. Wakabayashi, K. Yamauchi, S. Teraguchi and H. Hayasawa, 2002. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem. Cell Biol, 80: 109-112.
226. Tsuda, H, K. Sekine, Y. Ushida, T. Kuhara and N. Takasuka et al, 2000. Prevention of carcinogenesis and metastasis by dietary bovine lactoferrin. Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications, May 18-22, Sapporo, Japan, pp: 389-399.
227. Tsuda, H, K. Sekine, K. Fujita and M. Ligo, 2002. Cancer prevention by bovine lactoferrin and underlying mechanisms-A review of experimental and clinical studies. Biochem. Cell Biol, 80: 131-136.
228. Tsuji, S, Y. Hirata, F. Mukai and S. Ohtagaki, 1990. Comparison of lactoferrin content in colostrum between different cattle breeds. J. Dairy Sci, 73: 125-128.
229. U.S. Food and Drug Administration, 2001. Agency response letter GRAS Notice No. GRN 000077. CFSAN/Office of Food Additive Safety, Arlington, VA.
230. Uchida, Y, K. Sekine, T. Kuhara, N. Takasuka, M. Ligo, M. Maeda and H. Tsuda, 1999. Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn. J. Cancer Res, 90: 262-267.
231. Valenti, P, M. Marchetti, F. Superti, M.G. Amendoha and P. Puddu et al, 1998. Antiviral Activity of Lactoferrin. In: Advances in Lactoferrin Research, Spik, G. (Ed.). Plenum Press, New York, USA, ISBN-13: 9780306459269, pp: 199-203.
232. Valenti, P. and G. Antonini, 2005. Lactoferrin: An important host defence against microbial and viral attack. Cell. Mol. Life Sci, 62: 2576-2587.
233. Van Berkel, P.H, M.E. Geerts, H.A. van Veen, M. Mencskay, H.A. de Boer and J.H. Nmjens, 1997. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J, 328: 145-151.
234. Van Veen, H.A, M.E.J. Geerts, P.H.C. van Berkel and J.H. Nmjens, 2004. The role of N-lmked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. Eur. J. Biochem, 271: 678-684.
235. Vorland, L.H, 1999. Lactoferrin: A multifunctional glycoprotein. Acta Pathol. Microbiol. Immunol. Scand, 107: 971-981.
236. Wakabayashi, H, W. Bellamy, M. Takase and M. Tomito, 1994. Inactivation of Listeria monocytogenes by Lactoferricin, a potent antimicrobial peptide derived from cow's milk. J. Food Prot, 55: 238-240.
237. Wakabayashi, H, S. Abe, T. Okutomi, S. Tansho, K. Kawase and H. Yamaguchi, 1996. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol, 40: 821-825.
238. Wakabayashi, H, S. Abe, S. Teraguchi, H. Hayasawa and H. Yamaguchi, 1998. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob. Agents Chemother, 42: 1587-1591.
239. Wakabayashi, H, M. Takase and M. Tomita, 2003. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des, 9: 1277-1287.
240. Wakabayashi, H, K. Yamauchi and M. Takase, 2006. Lactoferrin research, technology and applications. Int. Dairy J, 16: 1241-1251.
241. Wang, D, K.M. Pabst, Y. Aida and M.J. Pabst, 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leuicoc Biol, 57: 865-874.
242. Ward, P.P., E. Paz and O.M. Conneely, 2005. Multifunctional roles of lactoferrin: A critical overview. Cell. Mol. Life Sci, 62: 2540-2548.
243. Watanabe, T, H. Nagura, K. Watanabe and W.R. Brown, 1984. The binding of human milk lactoferrin to immunoglobulin A. Fed. Eur. Biochem. Soc. Lett, 168: 203-207.
244. Weinberg, E.D, 2007. Antibiotic properties and applications of lactoferrin. Curr. Pharma. Des, 13: 801-811.
245. Wong, H. and AB. Schryvers, 2003. Bacterial lactoferrin-bin ding protein A binds to both domains of the human lactoferrin C-lobe. Microbiology, 149: 1729-1737.
246. Wood, R, 1988. The Whole Foods Encyclopedia: A Shopper's Guide. Prentice-Hall Press, New York, USA, ISBN-13: 9780139585548.
247. Yamamoto, H, Y. Ura, M. Tanemura, A. Koyama and T.S. Sayaka et al., 2010. Inhibitory effect of bovine lactoferrin on human parainfluenza virus type 2 Infection. J. Health Sci, 56: 613-617.
248. Yamauchi, K, M. Tomita, T.J. Giehl, R.T. Ellison III, 1993. Antibacterial activity of lactoferrin and pepsin-derived lactoferrin peptide fragment. Infec. Immun, 61: 719-728.
249. Yanaihara, A, R. Matusoka, Y. Toma, H. Saito, R. Makiino and T. Yanaihara, 2000. Effect of lactoferrin on human endometrial cell proliferation. Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications, May 18-22, Sapporo, Japan, pp: 353-360.
250. Yekta, M.A, F. Verdonck, W. Van Den Broeck, B.M. Goddeeris, E. Cox and D. Vanrompay, 2010. Lactoferrin inhibits E. coli 0157: H7 growth and attachment to intestinal epithelial cells. Vet. Med, 55: 359-368.
251. Yi, M, S. Kaneko, D.Y. Yu and S. Murakami, 1997. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol, 71: 5997-6002.
252. Zagulski, T, P. Lipinski, A. Zagulska, S. Broniek and Z. Jarzabek, 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol, 70: 697-704.
253. Zhang, P, V. Sawicki, A. Lewis, L. Hanson, J.H. Nuijens and M.C. Neville, 2001. Human lactoferrin in the milk of transgenic mice increases intestinal growth in ten-day-old suckling neonates. Adv. Exp. Med. Biol, 501: 107-113.
254. Zou, S, CE. Magura and W.L. Hurley, 1992. Heparin-binding properties of lactoferrin and lysozyme. Comp. Biochem. Physiol. B: Comp. Biochem, 130: 889-895.